Amneal Pharmaceuticals (AMRX) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 9:00 A.M. and conducted virtually, with agenda and rules provided on the meeting website.

• Participants instructed to submit one question each, limited to matters of general stockholder interest.

• Attendance confirmed by key executives, legal counsel, Inspector of Election, and independent auditor.

Board and executive committee updates

• Election of 10 directors to serve until the 2027 annual meeting presented as the first order of business.

Shareholder proposals

• Advisory, non-binding vote on executive compensation and ratification of Ernst & Young as independent auditor for 2026 included as proposals.

• Board recommended voting in favor of all proposals.